Author Paul, Friedemann

1 to 20 of 57 Items
  • 2022 Journal Article
    ​ ​Therapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS Registry​
    Frahm, N.; Fneish, F.; Ellenberger, D.; Flachenecker, P.; Paul, F.; Warnke, C. & Kleinschnitz, C. et al.​ (2022) 
    Neurology and Therapy,.​ DOI: https://doi.org/10.1007/s40120-021-00320-w 
    Details  DOI 
  • 2022 Journal Article
    ​ ​Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody–Associated Disease​
    Hümmert, M. W.; Schöppe, L. M.; Bellmann-Strobl, J.; Siebert, N.; Paul, F.; Duchow, A. & Pellkofer, H. et al.​ (2022) 
    Neurology98(11) pp. e1184​-e1196​.​ DOI: https://doi.org/10.1212/WNL.0000000000200052 
    Details  DOI 
  • 2021 Journal Article
    ​ ​Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder​
    Ayzenberg, I.; Richter, D.; Henke, E.; Asseyer, S.; Paul, F.; Trebst, C. & Hümmert, M. W. et al.​ (2021) 
    Neurology: Neuroimmunology & Neuroinflammation8(3) pp. e985​.​ DOI: https://doi.org/10.1212/NXI.0000000000000985 
    Details  DOI 
  • 2021 Journal Article | 
    ​ ​Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry​
    Ohle, L.-M.; Ellenberger, D. ; Flachenecker, P.; Friede, T. ; Haas, J.; Hellwig, K. & Parciak, T. et al.​ (2021) 
    Scientific Reports11(1) art. 13340​.​ DOI: https://doi.org/10.1038/s41598-021-92722-x 
    Details  DOI 
  • 2020 Journal Article | 
    ​ ​Antibody signatures in patients with histopathologically defined multiple sclerosis patterns​
    Stork, L.; Ellenberger, D.; Ruprecht, K.; Reindl, M.; Beißbarth, T. ; Friede, T. & Kümpfel, T. et al.​ (2020) 
    Acta Neuropathologica139(3) pp. 547​-564​.​ DOI: https://doi.org/10.1007/s00401-019-02120-x 
    Details  DOI  PMID  PMC 
  • 2020 Journal Article
    ​ ​Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders​
    Ringelstein, M.; Harmel, J.; Zimmermann, H.; Brandt, A. U.; Paul, F.; Haarmann, A. & Buttmann, M. et al.​ (2020) 
    Neurology94(4) pp. e407​-e418​.​ DOI: https://doi.org/10.1212/WNL.0000000000008684 
    Details  DOI 
  • 2020 Journal Article | 
    ​ ​Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients​
    Jarius, S.; Pellkofer, H. ; Siebert, N.; Korporal-Kuhnke, M.; Hümmert, M. W.; Ringelstein, M. & Rommer, P. S. et al.​ (2020) 
    Journal of Neuroinflammation17(1).​ DOI: https://doi.org/10.1186/s12974-020-01824-2 
    Details  DOI 
  • 2019 Journal Article | 
    ​ ​Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany​
    Bittner, S.; Engel, S.; Lange, C.; Weber, M. S. ; Haghikia, A.; Luessi, F. & Korn, T. et al.​ (2019) 
    Der Nervenarzt90(12) pp. 1245-1253​-1253​.​ DOI: https://doi.org/10.1007/s00115-019-0760-0 
    Details  DOI  PMID  PMC 
  • 2019 Journal Article
    ​ ​Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial​
    Levin, J.; Maaß, S.; Schuberth, M.; Giese, A.; Oertel, W. H; Poewe, W. & Trenkwalder, C.  et al.​ (2019) 
    The Lancet Neurology18(8) pp. 724​-735​.​ DOI: https://doi.org/10.1016/S1474-4422(19)30141-3 
    Details  DOI 
  • 2018 Journal Article
    ​ ​A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial)​
    Stürner, K. H.; Stellmann, J.-P.; Dörr, J.; Paul, F.; Friede, T. ; Schammler, S. & Reinhardt, S. et al.​ (2018) 
    Journal of Neurology, Neurosurgery & Psychiatry89(4) pp. 330​-338​.​ DOI: https://doi.org/10.1136/jnnp-2017-317101 
    Details  DOI 
  • 2017 Journal Article
    ​ ​Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response​
    Stellmann, J.-P.; Krumbholz, M.; Friede, T. ; Gahlen, A.; Borisow, N.; Fischer, K. & Hellwig, K. et al.​ (2017) 
    Journal of Neurology, Neurosurgery & Psychiatry88(8) pp. 639​-647​.​ DOI: https://doi.org/10.1136/jnnp-2017-315603 
    Details  DOI 
  • 2016 Journal Article
    ​ ​MRI phase changes in multiple sclerosis vs neuromyelitis optica lesions at 7T​
    Sinnecker, T.; Schumacher, S.; Mueller, K.; Pache, F.; Dusek, P. ; Harms, L. & Ruprecht, K. et al.​ (2016) 
    Neurology - Neuroimmunology Neuroinflammation3(4) pp. e259​.​ DOI: https://doi.org/10.1212/NXI.0000000000000259 
    Details  DOI 
  • 2016 Journal Article
    ​ ​Structural Hippocampal Damage Following Anti-N-Methyl-D-Aspartate Receptor Encephalitis​
    Finke, C.; Kopp, U. A.; Pajkert, A.; Behrens, J. R.; Leypoldt, F.; Wuerfel, J. T. & Ploner, C. J. et al.​ (2016) 
    Biological Psychiatry79(9) pp. 727​-734​.​ DOI: https://doi.org/10.1016/j.biopsych.2015.02.024 
    Details  DOI 
  • 2016 Journal Article | 
    ​ ​Progressive Multifocal Leukoencephalopathy in a Multiple Sclerosis Patient Diagnosed after Switching from Natalizumab to Fingolimod​
    Sinnecker, T.; Othman, J.; Kühl, M.; Metz, I. ; Niendorf, T.; Kunkel, A. & Paul, F. et al.​ (2016) 
    Case Reports in Neurological Medicine2016 pp. 1​-8​.​ DOI: https://doi.org/10.1155/2016/5876798 
    Details  DOI 
  • 2016 Journal Article | 
    ​ ​The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach (vol 123, pg 439, 2016)​
    Levin, J.; Maass, S.; Schuberth, M.; Respondek, G.; Paul, F.; Mansmann, U. & Oertel, W. H. et al.​ (2016) 
    Journal of Neural Transmission123(11) pp. 1357​-1358​.​ DOI: https://doi.org/10.1007/s00702-016-1602-x 
    Details  DOI  PMID  PMC  WoS 
  • 2016 Journal Article
    ​ ​Neuromyelitis optica does not impact periventricular venous density versus healthy controls: a 7.0 Tesla MRI clinical study​
    Schumacher, S.; Pache, F.; Bellmann-Strobl, J.; Behrens, J.; Dusek, P.; Harms, L. & Ruprecht, K. et al.​ (2016) 
    Magnetic Resonance Materials in Physics Biology and Medicine29(3) pp. 535​-541​.​ DOI: https://doi.org/10.1007/s10334-016-0554-3 
    Details  DOI  PMID  PMC  WoS 
  • 2016 Journal Article
    ​ ​Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case​
    Jarius, S.; Metz, I.; Koenig, F. B.; Ruprecht, K.; Reindl, M.; Paul, F. & Brueck, W. et al.​ (2016) 
    Multiple Sclerosis Journal22(12) pp. 1541​-1549​.​ DOI: https://doi.org/10.1177/1352458515622986 
    Details  DOI  PMID  PMC  WoS 
  • 2016 Journal Article
    ​ ​Iron and Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica Lesions at 7T MRI​
    Wuerfel, J.; Brisset, J. Brisset, J.- C.; Liu, S.; Haacke, E. M.; Ge, Y. ; Chawla, S. & Kister, I. et al.​ (2016) 
    American Journal of Neuroradiology37(7) pp. 1223​-1230​.​ DOI: https://doi.org/10.3174/ajnr.A4729 
    Details  DOI  PMID  PMC  WoS 
  • 2016 Journal Article
    ​ ​Monitoring of blood parameters under course-modified MS therapy. Substance-specific relevance and current recommendations for action​
    Klotz, L.; Berthele, A.; Brück, W. ; Chan, A.; Flachenecker, P.; Gold, R. & Haghikia, A. et al.​ (2016) 
    Der Nervenarzt87(6) pp. 645​-659​.​ DOI: https://doi.org/10.1007/s00115-016-0077-1 
    Details  DOI  PMID  PMC  WoS 
  • 2016 Journal Article | 
    ​ ​Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis​
    Metz, I. ; Beißbarth, T. ; Ellenberger, D. ; Pache, F.; Stork, L.; Ringelstein, M. & Aktas, O. et al.​ (2016) 
    Neurology: Neuroimmunology & Neuroinflammation3(2) art. e204​.​ DOI: https://doi.org/10.1212/NXI.0000000000000204 
    Details  DOI  PMID  PMC 

Researcher

Sort

issue date

ASC DESC

Items per Page